Status:
NOT_YET_RECRUITING
Retrospective Identification of Scintigraphic Cardiac Amyloidosis (RISCA)
Lead Sponsor:
University Hospital, Lille
Collaborating Sponsors:
Pfizer
Conditions:
Cardiac Amyloidosis
Transthyretin Amyloidosis
Eligibility:
All Genders
18+ years
Brief Summary
This study aims to determine the positive predictive value of incidental cardiac uptake on bone scintigraphy for diagnosing transthyretin cardiac amyloidosis, in patients who underwent scintigraphy fo...
Eligibility Criteria
Inclusion
- Adults (≥ 18 years)
- Patients who underwent bone scintigraphy with 99mTc-HMDP/DPD/PYP for any indication
- Incidental cardiac uptake (Perugini grade ≥2) confirmed by a nuclear medicine specialist
Exclusion
- Patients under legal protection
- Patients refusing the reuse of their data after individual information
Key Trial Info
Start Date :
June 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2027
Estimated Enrollment :
57 Patients enrolled
Trial Details
Trial ID
NCT06921408
Start Date
June 1 2025
End Date
December 1 2027
Last Update
April 10 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.